Influence of CYP2C9 Polymorphism on the Pharmacokinetics of Gliquidone in Chinese Healthy Subjects

XIONG Xiao-min,ZENG Cai-wen,YAN Fei,XIONG Yu-qing,XIA Chun-hua
DOI: https://doi.org/10.3969/j.issn.1001-6821.2011.10.007
2011-01-01
Abstract:Objective To investigate the influence of cytochrome P4502C9 polymorphism on the pharmacokinetics of gliquidone in Chinese healthy subjects.Methods Thirty-eight healthy subjects were genotyped by using RELP-PCR method and grouped according to the different CYP2C9 genotype.After oral administration of 60 mg gliquidone,the plasma concentrations of gliquidone in subjects were determined by HPLC-fluorescence detection method.The pharmacokinetic parameters of gliquidone were calculated and compared between different groups.Results There were 3 CYP2C9*1/*3 heterozygous mutants founded in 38 subjects.The others were all CYP2C9*1/*1 wild types and CYP2C9*3/*3 homozygous mutants were not found.After 17 wild type individuals and the three heterozygous mutants were given 60 mg gliquidone,it found that the AUC0-t,AUC0-∞ and CL/F of the heterozygous mutants were equivalent to 1.854,1.787 and 0.554-fold as those of the wild type individuals,respectively.Conclusion CYP2C9 genetic polymorphism has a significant influence on the pharmacokinetics of gliquidone in Chinese healthy subjects.Therefore,the clinical administration dosage of gliquidone should be adjusted in CYP2C9*1/*3 heterozygous mutants.
What problem does this paper attempt to address?